Treatment of agitation in bipolar disorder across the life cycle

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 4, 2003, Pages 3-9

  Alderfer, Benjamin S ^a   Allen, Michael H ^a,b  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b University North Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; HALOPERIDOL; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; BIPOLAR DISORDER; CONFUSION; DEPRESSION; DRUG EFFICACY; ENERGY; FALLING; FEMALE; HUMAN; IRRITABILITY; LIFE CYCLE; MALE; MANIA; MEDICAL DECISION MAKING; PREVALENCE; PRIORITY JOURNAL; SAFETY; SIDE EFFECT; TARDIVE DYSKINESIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHILD; COMORBIDITY; DISEASE PROGRESSION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; VALPROIC ACID;

EID: 0037257591     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
2. Swanson JW, Holzer CEI, Ganju VK, et al. Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hosp Community Psychiatry 1990;41:761-770
3. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA 1990;264:2511-2518
4. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-299
5. Allen MH, Currier GW. Diagnosis and treatment of mania in the psychiatric emergency service. Psychiatr Ann 2000;30:258-266
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
7. Dilsaver SC, Chen YR, Shoaib AM, et al. Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations. Am J Psychiatry 1999;156:426-430
8. Strakowski SM, McElroy SL, Keck PE, et al. Suicidality among patients with mixed and manic bipolar disorder. Am J Psychiatry 1996;153: 674-676
9. McElroy SL, Keck PE Jr, Pope HG, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633-1644
10. Liebenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996;153:163-173
11. Leibenluft E. Issues in the treatment of women with bipolar illness. J Clin Psychiatry 1997;58(suppl 15):5-11
12. Lindenmayer JP, Crowner M, Cosgrove V. Emergency treatment of agitation and aggression. In: Allen MH, ed. Emergency Psychiatry. Washington, DC: American Psychiatric Publishing; 2002:115-149
13. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, Scotland: E & S Livingston; 1921
14. Chang KD, Steiner H, Ketter TA, et al. Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry 2000;39:453-460
15. Carlson GA. Juvenile mania versus ADHD [letter]. J Am Acad Child Adolesc Psychiatry 1999;38:353-420
16. Geller B, Zimmerman B, Williams M, et al. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty, and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000; 10: 157-164
17. Geller B, Zimmerman B, Williams M, et al. Phenomenology of prepubertal and early adolescent bipolar disorder: examples of elated mood, grandiose behaviors, decreased need for sleep, racing thoughts, and hypersexuality. J Child Adolesc Psychopharmacol 2002;12:3-9
18. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 1997;36(suppl 10): 157S-176S
19. Geller B, Luby J. Child and adolescent bipolar disorder. J Am Acad Child Adolesc Psychiatry 1997;36:1168-1176
20. Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 1995;34:867-876
21. Bowring MA, Kovacs M. Difficulties in diagnosing manic disorders among children and adolescents. J Am Acad Child Adolesc Psychiatry 1992;31:611-614
22. McGlashan TH. Adolescent versus adult onset of mania. Am J Psychiatry 1988;145:221-223
23. Glasser M, Rabin P. Mania in the elderly. Age Ageing 1984;13:210-213
24. Shulman KI, Post F. Bipolar affective disorder in old age. Br J Psychiatry 1980;136:26-32
25. Wylie ME, Mulsant BH, Pollock BG, et al. Age of onset in geriatric bipolar disorder: effects on clinical presentation and treatment outcomes in an inpatient sample. Am J Geriatr Psychiatry 1999;7:77-83
26. Yassa R, Nair V, Nastase C, et al. Prevalence of bipolar disorder in a psychogeriatric population. J Affect Disord 1988;14:197-201
27. Young RC, Klerman GL. Mania in late life: focus on age at onset. Am J Psychiatry 1992;149:867-876
28. Shulman KI, Tohen M, Satlin A, et al. Mania compared with unipolar depression in old age. Am J Psychiatry 1992;149:341-345
29. Stone K. Mania in the elderly. Br J Psychiatry 1989;155:220-224
30. Sajatovic M, Popli A, Semple W. Ten-year use of hospital-based services by geriatric veterans with schizophrenia and bipolar disorder. Psychiatr Serv 1996;47:961-965
31. Yassa R, Nair NPV, Iskandar H. Late-onset bipolar disorder. Psychiatr Clin North Am 1988;11:117-131
32. Snowdon J. A retrospective case-note study of bipolar disorder in old age. Br J Psychiatry 1991;158:485-490
33. Kellner MB, Neher F. A first episode of mania after age 80. Can J Psychiatry 1991;36:607-608
34. Van Gerpen MW, Johnson JE, Winstead DK, et al. Mania in the geriatric patient population: a review of the literature. Am J Geriatr Psychiatry 1999;7:188-202
35. Allen MH, Currier GW, Hughes DH, et al. Expert Consensus Guideline Series: Treatment of Behavioral Emergencies. Postgrad Med 2001;1-88
36. Currier GW, Simpson GS. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 2001;62:153-157
37. Baker RW, Kinon BJ, Liu H, et al. Effectiveness of rapid initial dose escalation of oral olanzapine for acute agitation. Presented at the 2001 US Psychiatric and Mental Health Congress; Nov 15-18, 2001; Boston, Mass
38. Lindenmayer J-P, Kotsaftis A. Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry 2000;61:123-128
39. Daniel DG, Potkin SG, Reeves KR, et al. Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology 2001;155:128-134
40. Lesem MD, Zajecka JM, Swift RH, et al. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 2001;62:12-18
41. Meehan K, Zhang F, David S, et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 2001;21:389-397
42. Lilly UK. Products web page: Zyprexa. Available at: http://www.lilly.co.uk/products/drug.cfm?SPC_ID=12. Accessed Dec 6, 2002
43. Hirschfeld RMA, Allen MH, McEvoy J, et al. Safety and tolerability of oral divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 1999;60:815-818
44. Hirschfeld RMA, Baker JD, Wozniak P, et al. The safety and early efficacy of oral loaded divalproex versus standard titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry. In press
45. Limdi NA, Faught E. The safety of rapid valproic acid infusion. Epilepsia 2000;41:1342-1345
46. Grunze H, Erfurth A, Amann B, et al. Intravenous valproate loading in acutely manic and depressed bipolar patients. J Clin Psychopharmacol 1999;19:303-309
47. Cooper TB, Simpson GM. The 24-hour lithium level as a prognosticator of dosage requirements: a 2-year follow-up study. Am J Psychiatry 1976;133: 440-443
48. Prien RF, Caffey EM Jr, Klett CJ, et al. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiartry 1972;26:146-153
49. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind, placebo controlled trial. Clin Neuropharmacol 1998;21:176-180
50. Hirschfeld R, Keck PE, Kascherk, et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-contolled trial. Presented at the American College of Neuropsychopharmacology 41st Annual Meeting; Dec 8-12, 2002; San Juan, PR
51. Tohen M, Jacobs TG, Grundy SL, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo controlled study. Arch Gen Psychiatry 2000;57:841-849
52. Tohen M, Sanger TM, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999;156:702-709
53. Giller EL, Mandel FS, Keck P. Ziprasidone in the acute treatment of mania: a double-blind, placebo-controlled, randomized trial [abstract]. Schizophr Res 2001;49(suppl 1-2):229
54. Casey DE, Daniel DG, Wassef AA, et al. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003;28:182-192
55. Sachs GS, Grossman F, Ghaemi SN, et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146-1154
56. Chou JC-Y, Czobor P, Charles O, et al. Acute mania: haloperidol dosage and augmentation with lithium or lorazepam. J Clin Psychopharmacol 1999;19:500-505
57. Sachs G, Mullen JA, Devine NA, et al. Quetiapine versus placebo as adjunct to mood stabilizer in the treatment of acute bipolar mania. Presented at the 3rd European Stanley Foundation Conference on Bipolar Disorder; Sept 12-14, 2002; Freiburg, Germany
58. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39:713-720
59. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-1388
60. Irwin M, Masand P. Valproate and polycystic ovaries [letter, comment]. J Am Acad Child Adolesc Psychiatry 1998;37:9-10
61. DelBello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:1216-1223
62. Soutullo C, Sorter M, Foster KD, et al. Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 1999;53: 279-283
63. Chang KD, Ketter TA. Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psychopharmacol 2000;10:45-49
64. Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001;11:239-50
65. Snyder R, Turgay A, Aman M, et al. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQ's. J Am Acad Child Adolesc Psychiatry 2002;41:1026-1036
66. Sandor P, Stephens RJ. Risperidone treatment of aggressive behavior in children with Tourette's syndrome. J Clin Psychopharmacol 2000;20: 710-712
67. Schreier HA. Risperidone for young children with mood disorders and aggressive behavior. J Child Adolesc Psychopharmacol 1998;8:49-59
68. Jeste DV, Caligiuri MP, Palmer B, et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 1995;52:756-765
69. Katz IR, Jeste DV, Mintzer JE, et al, for the Risperidone Study Group. Comparison of risperidone and placebo for psychosis and behavioral disturbance associated with dementia: a randomized, double-blind study. J Clin Psychiatry 1999;60:107-115
70. Tariot PN, Schneider LS, Mintzer JE, et al. Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial. Curr Ther Res 2001;62:51-67
71. Porteinsson AP, Tariot PN, Erb RE, et al. Placebo-controlled study in divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry 2001;9: 58-66